Corcept Therapeutics Inc (NASDAQ:CORT)

18.56
Delayed Data
As of May 18
 +0.58 / +3.23%
Today’s Change
10.40
Today|||52-Week Range
25.96
+2.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-31.4M-6.4M8.1M129.1M
 
 
 
 
 
Depreciation141.0K155.0K87.0K106.0K
 
 
 
 
 
Total Other Cash Flow8.9M8.9M9.0M14.1M
 
 
 
 
 
Funds From Operations-22.3M2.6M17.2M66.6M
 
 
 
 
 
Funds From/For Other Operating Expenses5.0M-500.0K-1.2M5.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-27.4M3.1M18.4M60.9M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-73.0M
 
 
Capital Expenditures-174.0K-17.0K-194.0K-419.0K
 
 
 
 
 
Net Cash Flow Investing-174.0K-17.0K-194.0K-73.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.000.00--0.00--
Long Term Debt Reduction-4.9M-9.2M-14.8M-15.1M
 
 
 
 
 
Net Proceeds Stock Sale1.8M22.3M7.7M7.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-3.1M13.1M-7.1M-8.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-30.6M16.2M11.1M-20.5M